Philadelphia, PA, United States of America

Ronald F Tuma

This inventor holds 1 USPTO granted patent. Top assignees: Organix, Inc., Temple University, Virginia Commonwealth University. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald F Tuma. Retrieved from https://idiyas.com/inventor/ronald-f-tuma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ronald F. Tuma

Introduction

Ronald F. Tuma is an accomplished inventor based in Philadelphia, PA. He is known for his significant contributions to the field of inflammation therapy. With a focus on central nervous system inflammation, Tuma has developed innovative methods that utilize cannabinoid agonists for therapeutic purposes.

Latest Patents

Tuma holds one patent related to his work in inflammation therapy. This patent describes a method for treating patients suffering from central nervous system inflammation. The method involves administering a therapeutically effective amount of a cannabinoid agonist that has efficacy at the CB receptor while having substantially no efficacy at the CB receptor at that amount.

Career Highlights

Throughout his career, Ronald F. Tuma has worked with notable institutions, including Virginia Commonwealth University and Organix, Inc. His work in these organizations has allowed him to advance his research and contribute to the field of cannabinoid therapy.

Collaborations

Tuma has collaborated with several professionals in his field, including Billy R. Martin and Mohamad I. Damaj. These collaborations have enriched his research and expanded the impact of his innovations.

Conclusion

Ronald F. Tuma's work in inflammation therapy showcases his dedication to advancing medical treatments through innovative methods. His contributions have the potential to significantly improve patient care in the realm of central nervous system inflammation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…